ATE490469T1 - Beurteilung des skelettwachstums unter verwendung von messungen von nt-cnp-peptiden - Google Patents

Beurteilung des skelettwachstums unter verwendung von messungen von nt-cnp-peptiden

Info

Publication number
ATE490469T1
ATE490469T1 AT04748820T AT04748820T ATE490469T1 AT E490469 T1 ATE490469 T1 AT E490469T1 AT 04748820 T AT04748820 T AT 04748820T AT 04748820 T AT04748820 T AT 04748820T AT E490469 T1 ATE490469 T1 AT E490469T1
Authority
AT
Austria
Prior art keywords
growth
cnp
plasma
assessment
provides
Prior art date
Application number
AT04748820T
Other languages
English (en)
Inventor
Timothy Charles Ramsey Prickett
Eric Arnold Espiner
Arthur Mark Richards
Timothy Grant Yandle
Michael Gary Nicholls
Original Assignee
Otago Innovation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otago Innovation Ltd filed Critical Otago Innovation Ltd
Application granted granted Critical
Publication of ATE490469T1 publication Critical patent/ATE490469T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575—Hormones
    • G01N2333/58—Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Brain natriuretic peptide [BNP, proBNP]; Cardionatrin; Cardiodilatin
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/10—Musculoskeletal or connective tissue disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
AT04748820T 2003-06-17 2004-06-17 Beurteilung des skelettwachstums unter verwendung von messungen von nt-cnp-peptiden ATE490469T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NZ52652603 2003-06-17
PCT/NZ2004/000125 WO2004111653A1 (en) 2003-06-17 2004-06-17 Assessment of skeletal growth using measurements of nt-cnp peptides

Publications (1)

Publication Number Publication Date
ATE490469T1 true ATE490469T1 (de) 2010-12-15

Family

ID=33550523

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04748820T ATE490469T1 (de) 2003-06-17 2004-06-17 Beurteilung des skelettwachstums unter verwendung von messungen von nt-cnp-peptiden

Country Status (7)

Country Link
US (1) US7919255B2 (de)
EP (1) EP1644740B1 (de)
AT (1) ATE490469T1 (de)
CA (1) CA2570398C (de)
DE (1) DE602004030342D1 (de)
DK (1) DK1644740T3 (de)
WO (1) WO2004111653A1 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004105575A2 (en) * 2003-05-29 2004-12-09 Trustee Of Darmouth College A method for detecting cardiac ischemia via changes in b-natriuretic peptide levels
PL1759001T3 (pl) 2004-04-21 2011-09-30 Alexion Pharma Inc Koniugaty dostarczane do kości i sposób ich zastosowania do nakierowywania białek do kości
US8735142B2 (en) * 2005-08-16 2014-05-27 Chipotle Business Group, Inc. Systems and methods for immunosorbent assays for single and multiple analytes
US7767404B2 (en) * 2005-08-16 2010-08-03 Chipotle Business Group, Inc. Apparatus and method for single-step immunosorbent assay for single and multiple analytes
EP2432489B1 (de) 2009-05-20 2016-10-05 BioMarin Pharmaceutical Inc. Varianten des natriuretischen peptids typ c
JP6055779B2 (ja) 2010-12-27 2016-12-27 アレクシオン ファーマシューティカルズ， インコーポレイテッド ナトリウム利尿ペプチドを含む組成物およびその使用方法
US10052366B2 (en) 2012-05-21 2018-08-21 Alexion Pharmaceuticsl, Inc. Compositions comprising alkaline phosphatase and/or natriuretic peptide and methods of use thereof
IN2015KN00571A (de) * 2012-08-13 2015-07-17 Otago Innovation Ltd
WO2016007873A1 (en) 2014-07-11 2016-01-14 The Regents Of The University Of Michigan Compositions and methods for treating craniosynostosis
JP6787894B2 (ja) 2014-12-05 2020-11-18 アレクシオン ファーマシューティカルズ， インコーポレイテッド 組換えアルカリホスファターゼを用いた発作の処置
CA2973883A1 (en) 2015-01-28 2016-08-04 Alexion Pharmaceuticals, Inc. Methods of treating a subject with an alkaline phosphatase deficiency
JP6993961B2 (ja) 2015-08-17 2022-01-14 アレクシオン ファーマシューティカルズ， インコーポレイテッド アルカリホスファターゼの製造
EP3355904A4 (de) 2015-09-28 2019-06-12 Alexion Pharmaceuticals, Inc. Identifizierung wirksamer dosierungsschemata für gewebeunspezifische alkalische phosphatase-enzymersatztherapie von hypophosphatasie
EP3368062A4 (de) 2015-10-30 2019-07-03 Alexion Pharmaceuticals, Inc. Verfahren zur behandlung von craniosynostose bei einem patienten
US11065306B2 (en) 2016-03-08 2021-07-20 Alexion Pharmaceuticals, Inc. Methods for treating hypophosphatasia in children
KR20180125979A (ko) 2016-04-01 2018-11-26 알렉시온 파마슈티칼스, 인코포레이티드 알칼리성 포스파타아제로 근육 약화의 치료
US10898549B2 (en) 2016-04-01 2021-01-26 Alexion Pharmaceuticals, Inc. Methods for treating hypophosphatasia in adolescents and adults
WO2017214130A1 (en) 2016-06-06 2017-12-14 Alexion Pharmaceuticals, Inc. Metal impact on manufacturing of alkaline phosphatases
US20170363620A1 (en) 2016-06-17 2017-12-21 Abbott Laboratories BIOMARKERS TO PREDICT NEW ONSET HEART FAILURE WITH PRESERVED EJECTION FRACTION (HFpEF)
JP7018933B2 (ja) 2016-08-18 2022-02-14 アレクシオン ファーマシューティカルズ， インコーポレイテッド 気管気管支軟化症の治療方法
KR20190129058A (ko) 2017-03-31 2019-11-19 알렉시온 파마슈티칼스, 인코포레이티드 성인 및 청소년에서 저포스파타제증 (hpp)을 치료하는 방법
WO2019190752A1 (en) 2018-03-30 2019-10-03 Alexion Pharmaceuticals, Inc. Manufacturing of glycoproteins
WO2020033867A2 (en) 2018-08-10 2020-02-13 Alexion Pharmaceuticals, Inc. Methods of treating neurofibromatosis type 1 and related conditions with alkaline phosphatase
CA3161266A1 (en) 2019-12-09 2021-06-17 Alexion Pharmaceuticals, Inc. Alkaline phosphatase polypeptides and methods of use thereof
US12611447B2 (en) 2020-09-04 2026-04-28 Alexion Pharmaceuticals, Inc. Methods for treating bone mineralization disorders
AU2022218782B2 (en) 2021-02-12 2026-06-25 Alexion Pharmaceuticals, Inc. Alkaline phosphatase polypeptides and methods of use thereof
CN119619532A (zh) * 2024-10-30 2025-03-14 中国科学院动物研究所 一种用于评价和/或预测骨骼发育状况的试剂盒和方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT407580B (de) 1999-08-20 2001-04-25 Biomedica Gmbh Indikatorpeptid zur diagnose und/oder vorhersage von cardiovasculären und/oder endothelialen erkrankungen, antikörperzusammensetzung und immunoassay
US20030219734A1 (en) * 2001-04-13 2003-11-27 Biosite Incorporated Polypeptides related to natriuretic peptides and methods of their identification and use

Also Published As

Publication number Publication date
US7919255B2 (en) 2011-04-05
EP1644740A1 (de) 2006-04-12
DE602004030342D1 (de) 2011-01-13
EP1644740A4 (de) 2007-12-12
US20070292966A1 (en) 2007-12-20
EP1644740B1 (de) 2010-12-01
CA2570398C (en) 2020-05-12
DK1644740T3 (da) 2011-02-21
WO2004111653A1 (en) 2004-12-23
CA2570398A1 (en) 2004-12-23

Similar Documents

Publication Publication Date Title
EP1644740A4 (de) Beurteilung des skelettwachstums unter verwendung von messungen von nt-cnp-peptiden
KR101256133B1 (ko) 전기화학적 분석대상물 검출 동안에 비정상적인 경로의검출을 위한 방법 및 장치
NO20063816L (no) Systemer og fremgangsmater for avfoling av blodglykose
Yetley et al. Biomarkers of vitamin B-12 status in NHANES: a roundtable summary
Hosoi et al. Quantitative analysis of calcium-dependent vesicle recruitment and its functional role at the calyx of Held synapse
Sargent et al. Rapid vesicular release, quantal variability, and spillover contribute to the precision and reliability of transmission at a glomerular synapse
Shetty et al. Developmental validation of a point-of-care, salivary α-amylase biosensor
TW200745543A (en) System and methods for providing corrected analyte concentration measurements
CA2535833A1 (en) Method and apparatus for assay of electrochemical properties
Castanheira et al. Predicting cardiometabolic disturbances from waist-to-height ratio: findings from the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil) baseline
EP2042865A3 (de) Systeme und Verfahren zur Unterscheidung zwischen einer Kontrolllösung und einer physiologischen Probe
CY1117095T1 (el) Συσκευη και μεθοδος για ηλεκτροχημικη ανιχνευση
Kang et al. Reliable clinical serum analysis with reusable electrochemical sensor: Toward point-of-care measurement of the antipsychotic medication clozapine
BRPI0814202A2 (pt) Métodos e sistemas de determinação de concentração de produto de análise em amostra fluida e meio legível em computador
BRPI0309503A8 (pt) Fitas de teste, métodos de produção e uso de pluralidade de fitas de teste, de medição de glicose em amostra de sangue e de identificação de fita, dispositivo de armazenamento de dados removível para medidor e medidores
US20210076999A1 (en) Systems and methods for the detection and quantification of ammonia and ammonium in fluids
MXPA02010106A (es) Determinacion de suficiencia de volumen de muestra en dispositivos biosensores.
TW200413718A (en) Method and system for determining the acceptability of signal data collected from a prothrombin time test strip
Frank et al. Performance of the CONTOUR® TS blood glucose monitoring system
ATE370414T1 (de) Verwendung von nicotinamide n-methyltransferase zur diagnose von kolorektalem krebs
ATE468535T1 (de) Verwendung von nnmt als marker für lungenkrebs
US9869654B2 (en) Method of measuring hematocrit (HCT), and measurement device using the method
Petrov et al. BIOLOGICAL AGE ESTIMATION OF THE PARTICIPANTS IN THE 32-ND BULGARIAN ANTARCTIC EXPEDITION
WO2004093784A3 (en) Systems and methods for blood glucose sensing
Azizi et al. Measurement of plasma renin: a critical review of methodology

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties